<unk>  (ARIA) are abnormal differences seen in magnetic resonance<unk>  of the brain of Alzheimer's disease patients, associated with<unk> -modifying therapies, particularly human monoclonal antibodies such as aducanumab. There are two types of ARIA - ARIA-E and ARIA-H. The phenomenon was first seen in trials of bapineuzumab.
Amyloid-related imaging abnormalities
Oral manifestations of systemic disease
Pathology of multiple sclerosis
Neurocristopathy
Multiple sclerosis diagnosis
Multiple sclerosis biomarkers
symptom of Alzheimer's disease
Multiple sclerosis signs and symptoms